Cargando…
Defining the risk of first intravenous immunoglobulin unresponsiveness in non-Asian patients with Kawasaki disease
About 10–20% of patients with Kawasaki disease (KD) are unresponsive to intravenous immunoglobulin (IVIg) and are at increased risk of coronary artery abnormalities (CAAs). Early identification is critical to initiate aggressive therapies, but available scoring systems lack sensitivity in non-Japane...
Autores principales: | Piram, Maryam, Darce Bello, Martha, Tellier, Stéphanie, Di Filippo, Sylvie, Boralevi, Franck, Madhi, Fouad, Meinzer, Ulrich, Cimaz, Rolando, Piedvache, Celine, Koné-Paut, Isabelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033244/ https://www.ncbi.nlm.nih.gov/pubmed/32080307 http://dx.doi.org/10.1038/s41598-020-59972-7 |
Ejemplares similares
-
Importance of predicting non-response to intravenous immunoglobulin therapy in non-Asian patients with Kawasaki disease
por: Koné-Paut, Isabelle, et al.
Publicado: (2022) -
Kawasaki disease in France, Kawanet: incomplete forms are frequent and associated with a high frequency of cardiac complications
por: Koné-Paut, I, et al.
Publicado: (2014) -
Is it Kawasaki shock syndrome, Kawasaki-like disease or pediatric inflammatory multisystem disease? The importance of semantic in the era of COVID-19 pandemic
por: Koné-Paut, Isabelle, et al.
Publicado: (2020) -
Kawasaki disease: Aetiopathogenesis and therapeutic utility of intravenous immunoglobulin
por: Galeotti, Caroline, et al.
Publicado: (2010) -
Editorial: Pathogenesis, Clinical Findings, and Treatment Advances in Kawasaki Disease
por: Giani, Teresa, et al.
Publicado: (2021)